Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial of Efficacy and Safety of Remaxol®, a Solution for Intravenous Infusions Produced by STPF "POLYSAN" (Russia), in Patients With Mechanical Jaundice of Non-Malignant Origin
Conditions
Interventions
Remaxol (succinate + methionine + inosine + nicotinamide)
Ringer's Solution
Locations
13
Russia
Moscow 'City Clinical Hospital #24
Moscow, Russia
Moscow City Clinical Hospital #1 n.a.N.I.Pirogov
Moscow, Russia
Moscow City Clinical Hospital #29 n.a.N.A.Bauman
Moscow, Russia
Moscow City Clinical Hospital #67 n.a. L.A.Vorohobova
Moscow, Russia
Novosibirsk State Medical University
Novosibirsk, Russia
City Clinical Hospital of Emergency Care
Ryazan, Russia
Start Date
April 3, 2017
Primary Completion Date
March 31, 2020
Completion Date
April 13, 2020
Last Updated
July 14, 2020
NCT06197984
NCT06196164
NCT03527875
NCT03252379
Lead Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions